Consideration of a North American heroin-assisted clinical trial for the treatment of opiate-dependent individuals

International Journal of Drug Policy

Volumn 11, Issue 5, 2000, Pages 357-370

  Kuo, Irene ^a   Fischer, Benedikt ^b   Vlahov, David ^a,c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c NEW YORK ACADEMY OF MEDICINE   (United States)

Author keywords

Canada; Heroin assisted therapy; Injection drug user; Methadone; Opiate dependence; United States

Indexed keywords

BUPRENORPHINE; DIAMORPHINE; LEVACETYLMETHADOL; METHADONE;

CLINICAL TRIAL; CRIMINAL BEHAVIOR; DRUG DEPENDENCE; DRUG EFFICACY; ECONOMIC ASPECT; HUMAN; LONG TERM CARE; MORBIDITY; MORTALITY; NORTH AMERICA; OPIATE ADDICTION; PRIORITY JOURNAL; REVIEW; SOCIAL ASPECT;

EID: 0034284743     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-3959(00)00057-8     Document Type: Article

References (104)

1. The importance of preventing hepatitis C virus infection among injection drug users in the United States
2. The heroin prescribing debate: Integrating science and politics
3. The cost-effectiveness of methadone maintenance as a health care intervention
4. Horse trading: Prescribing injectable opiates to opiate addicts. A descriptive study
5. Heroin maintenance
6. Methadone maintenance treatment: An update
7. The income-generating behaviour of injecting drug users in Oslo
8. Bacterial pneumonia in populations with HIV infection
9. The medical complications of drug addiction and the medical assessment of the intravenous drug user: 25 Years later
10. German doctors vote to prescribe heroin to misusers
11. Fatal heroin 'overdose': A review
12. Heroin substitution in Canada: A necessary public health intervention
13. The first and second decades of AIDS among injection drug users
14. A medical treatment for diacetylmorphine (heroin) addiction
15. Controlled clinical evaluation of diacetyl morphine for treatment of intractable opiate dependence
16. Comparison of buprenorphine and methadone maintenance in opiate addicts
17. The Swiss heroin trials: Testing alternative approaches: Prescribed heroin is likely to have a limited role
18. Fortnightly review: Methadone maintenance treatment in opiate dependence: A review
19. Prohibition, prescriptions and politics. The turbulent history of methadone maintenance in Canada
20. The case for a heroin substitution treatment trial in Canada
21. Charting WHO goals for licit and illicit drugs for the year 2000: Are we on track?
22. Illicit opiates in Toronto: A profile of current users
23. Viral infection in short-term injection drug users: The prevalence of hepatitis C, hepatitis B, human immunodeficiency and human T-lymphotropic virus
24. Heroin addiction, crime and economic cost
25. Methadone vs. L-alpha-acetylmethadol (LAAM) in the treatment of opiate addiction. A meta-analysis of the randomized, controlled trials
26. Alternative pharmacotherapies for opiate addiction
27. Management of the narcotic addict
28. Aug. evaluation of heroin maintenance in controlled trial
29. Serious infections other than human immunodeficiency virus among intravenous drug abusers
30. The estimated prevalence and incidence of HIV in 96 large U.S. metropolitan areas
31. It takes your heart: The image of methadone maintenance in the addict world and its effect on recruitment
32. Outpatient detoxification from opiates
33. Heroin maintenance for heroin addicts: Issues and evidence
34. Treatment of heroin addicts using buprenorphine
35. Medically indicated heroin prescription in the treatment of drug addicts: Clinical trials and developments in research in Europe
36. Medical safety and side effects of methadone in tolerant individuals
37. Rationale for maintenance pharmacotherapy of opiate dependence
38. Differences in the incidence of hepatitis B and human immunodeficiency virus among injecting drug users
39. Methadone injecting in Australia: A tale of two cities
40. Methadone maintenance
41. Human immundeficiency virus infection and infective endocarditis among injection drug users
42. A case for heroin maintenance
43. Psychosocial services in substance abuse treatment? A dose-ranging study of psychosocial services
44. Feasibility of prescribing injectable heron and methadone to opiate-dependent drug users: Associated health gains and harm reductions
45. HIV seroconversion among in and out of treatment intravenous drug users: An 18-month prospective follow-up
46. Drug abuse treatment as AIDS prevention
47. Doing methadone right
48. Effective medical treatment of opiate addiction
49. The criminality of narcotics addicts
50. Drug abuse, crime costs and the economic benefits of treatment
51. Methadone programmes. The cost and benefits to society and the individual
52. Modes de consommation et repartition des drogues en Suisse
53. Heroin maintenance: Is a U.S. experiment needed? Presented at 'One Hundred Years of Heroin' Conference, Yale Medical School, New Haven
54. The Swiss heroin trials: Scientifically sound?
55. Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users
56. Adolescent heroin use: A review
57. Methadone maintenance treatment
58. Methadone in the treatment of opioid dependence: A review of world literature
59. Addiction careers: Etiology, treatment and 12-year follow-up procedures
60. Terminology for drug injection practices among intravenous drug users in Baltimore
61. Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus
62. Acute heroin overdose
63. Methadone diversion: A new look
64. Prescribing heroin and other injectable drugs
65. Needle exchange is not enough: Lessons from the Vancouver injecting drug use study
66. Can HIV epidemics among injection drug users be prevented?
67. Correlates of hepatitis C virus infections among injection drug users in Baltimore, Maryland
68. ALIVE Study: A longitudinal study of HIV infection among intravenous drug users
69. Overstating the case: Methodological comments on 'The Effects of Harm Reduction in Amsterdam' by Buning and van Brussel
70. The social cost of untreated opioid dependence
71. Attitudes toward methadone maintenance: Implications for HIV prevention